The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Virax Biolabs Group Ltd’s current trading price is -76.67% away from its 52-week high, while its distance from the 52-week low is 250.00%. The stock’s price range for this period has been between $0.60 and $9.00 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.94 million for the day, a number notably lower than the average daily volume of 1.8 million over the last three months.
Virax Biolabs Group Ltd experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $9.00 on 08/19/24, while the lowest price for the same period was registered at $0.60 on 05/03/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Virax Biolabs Group Ltd (VRAX) has experienced a quarterly rise of 8.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.11M and boasts a workforce of 17 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.35, with a change in price of +1.07. Similarly, Virax Biolabs Group Ltd recorded 4,035,825 in trading volume during the last 100 days, posting a change of +103.88%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VRAX stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.04.
VRAX Stock Stochastic Average
Virax Biolabs Group Ltd’s raw stochastic average for the past 50 days is presently 29.63%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 67.66%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 38.78% and 31.46%, respectively.
VRAX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 43.84% this year. Over the last six months, there has been a weaker performance of 81.03%. The price of VRAX fallen by 3.96% during the last 30 days period. For the last 5-days stocks have improved 11.11%.
